134 related articles for article (PubMed ID: 22262764)
1. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.
Engelhardt BG; Jagasia SM; Crowe JE; Griffith ML; Savani BN; Kassim AA; Lu P; Weitkamp JH; Moore DJ; Yoder SM; Rock MT; Jagasia M
Blood; 2012 Mar; 119(10):2417-21. PubMed ID: 22262764
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.
Engelhardt BG; Sengsayadeth SM; Jagasia M; Savani BN; Kassim AA; Lu P; Shyr Y; Yoder SM; Rock MT; Crowe JE
Exp Hematol; 2012 Dec; 40(12):974-982.e1. PubMed ID: 22885125
[TBL] [Abstract][Full Text] [Related]
3. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.
Griffith ML; Jagasia MH; Misfeldt AA; Chen H; Engelhardt BG; Kassim A; Savani BN; Survant M; Jagasia SM
Biol Blood Marrow Transplant; 2011 Jan; 17(1):86-92. PubMed ID: 20561594
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.
Johnpulle RA; Paczesny S; Jung DK; Daguindau E; Jagasia MH; Savani BN; Chinratanalab W; Cornell RF; Goodman S; Greer JP; Kassim AA; Sengsayadeth S; Byrne MT; Engelhardt BG
Biol Blood Marrow Transplant; 2017 Mar; 23(3):529-532. PubMed ID: 28013014
[TBL] [Abstract][Full Text] [Related]
5. New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications.
Engelhardt BG; Savani U; Jung DK; Powers AC; Jagasia M; Chen H; Winnick JJ; Tamboli RA; Crowe JE; Abumrad NN
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1225-1231. PubMed ID: 30738170
[TBL] [Abstract][Full Text] [Related]
6. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
[TBL] [Abstract][Full Text] [Related]
7. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
[TBL] [Abstract][Full Text] [Related]
8. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
Matsuoka K; Kim HT; McDonough S; Bascug G; Warshauer B; Koreth J; Cutler C; Ho VT; Alyea EP; Antin JH; Soiffer RJ; Ritz J
J Clin Invest; 2010 May; 120(5):1479-93. PubMed ID: 20389017
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes.
Engelhardt BG; Jagasia M; Savani BN; Bratcher NL; Greer JP; Jiang A; Kassim AA; Lu P; Schuening F; Yoder SM; Rock MT; Crowe JE
Bone Marrow Transplant; 2011 Mar; 46(3):436-42. PubMed ID: 20577222
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk Factors of Posttransplantation Diabetes Mellitus in Living Donor Kidney Transplantation: A Single-Center Retrospective Study in China.
Xu J; Xu L; Wei X; Li X; Cai M
Transplant Proc; 2018 Dec; 50(10):3381-3385. PubMed ID: 30471834
[TBL] [Abstract][Full Text] [Related]
11. Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity.
Schachtner T; Stein M; Reinke P
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28423197
[TBL] [Abstract][Full Text] [Related]
12. Using analytic morphomics to describe body composition associated with post-kidney transplantation diabetes mellitus.
Cron DC; Noon KA; Cote DR; Terjimanian MN; Augustine JJ; Wang SC; Englesbe MJ; Woodside KJ
Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28640481
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Posttransplantation Diabetes Mellitus After Liver Transplantation: Assessment of Insulin Administration as a Risk Factor.
Linder KE; Baker WL; Rochon C; May ST; Sheiner PA; Martin ST
Ann Pharmacother; 2016 May; 50(5):369-75. PubMed ID: 26847860
[TBL] [Abstract][Full Text] [Related]
14. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
Locke FL; Pidala J; Storer B; Martin PJ; Pulsipher MA; Chauncey TR; Jacobsen N; Kröger N; Walker I; Light S; Shaw BE; Beato F; Laport GG; Nademanee A; Keating A; Socie G; Anasetti C
Biol Blood Marrow Transplant; 2017 Mar; 23(3):405-411. PubMed ID: 28007665
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients.
Hur KY; Kim MS; Kim YS; Kang ES; Nam JH; Kim SH; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
Diabetes Care; 2007 Mar; 30(3):609-15. PubMed ID: 17327329
[TBL] [Abstract][Full Text] [Related]
16. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism.
Yao B; Chen X; Shen FX; Xu W; Dong TT; Chen LZ; Weng JP
Transplant Proc; 2013; 45(1):194-6. PubMed ID: 23375298
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation.
Velaga S; Ukena SN; Höpting M; Ivanyi P; Borchers S; Mischak-Weissinger EM; Hamwi I; Buchholz S; Ganser A; Franzke A
Immunol Invest; 2013; 42(1):18-35. PubMed ID: 23083129
[TBL] [Abstract][Full Text] [Related]
19. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus after living donor liver transplantation: data from mainland China.
Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
